GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (OTCPK:NVSEF) » Definitions » Quick Ratio

Novartis AG (Novartis AG) Quick Ratio

: 0.93 (As of Dec. 2023)
View and export this data going back to 1996. Start your Free Trial

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Novartis AG's quick ratio for the quarter that ended in Dec. 2023 was 0.93.

Novartis AG has a quick ratio of 0.93. It indicates that the company cannot currently fully pay back its current liabilities.

The historical rank and industry rank for Novartis AG's Quick Ratio or its related term are showing as below:

NVSEF' s Quick Ratio Range Over the Past 10 Years
Min: 0.68   Med: 0.92   Max: 1.29
Current: 0.93

During the past 13 years, Novartis AG's highest Quick Ratio was 1.29. The lowest was 0.68. And the median was 0.92.

NVSEF's Quick Ratio is ranked worse than
64.56% of 1075 companies
in the Drug Manufacturers industry
Industry Median: 1.34 vs NVSEF: 0.93

Novartis AG Quick Ratio Historical Data

The historical data trend for Novartis AG's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Quick Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.83 0.68 1.29 1.04 0.93

Novartis AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Quick Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.04 0.79 0.79 0.83 0.93

Competitive Comparison

For the Drug Manufacturers - General subindustry, Novartis AG's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novartis AG Quick Ratio Distribution

For the Drug Manufacturers industry and Healthcare sector, Novartis AG's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Novartis AG's Quick Ratio falls into.



Novartis AG Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Novartis AG's Quick Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Quick Ratio (A: Dec. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(30481-5913)/26390
=0.93

Novartis AG's Quick Ratio for the quarter that ended in Dec. 2023 is calculated as

Quick Ratio (Q: Dec. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(30481-5913)/26390
=0.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novartis AG  (OTCPK:NVSEF) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Novartis AG Quick Ratio Related Terms

Thank you for viewing the detailed overview of Novartis AG's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Novartis AG (Novartis AG) Business Description

Address
Lichtstrasse 35, Basel, CHE, 4056
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Novartis AG (Novartis AG) Headlines

From GuruFocus

Novartis' Strategic Plan Brings Many Plusses

By Barry Cohen 09-28-2022

Top 5 2nd Quarter Trades of TEALWOOD ASSET MANAGEMENT INC

By GuruFocus Research GuruFocus Editor 07-20-2022